SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid renewed scrutiny of President Trump's ties to Jeffrey Epstein, with discussions focusing on newly released emails and reports of Trump's efforts to suppress the release of Epstein files. The community is actively debating the implications of these revelations, with some questioning Trump's motives and others defending him against what they claim are politically motivated attacks. This heightened attention coincides with broader market discussions around the stock's fundamentals and potential for volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid discussions around the potential end of the government shutdown and its impact on the market, with some anticipating a "sell the news" event. Community chatter also revolves around the possible release of the Epstein files and their potential market implications, creating uncertainty and volatility. Additionally, economic data releases are in focus, as the White House suggests October numbers may not be released.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax ($NVAX) is trending due to activist investor Shah Capital's continued pressure on management, including calls for a company sale, which has sparked debate among retail investors regarding the company's future direction. The community is actively discussing Shah's criticisms of Novavax's leadership and strategy, particularly concerning the Sanofi partnership and the lagging COVID vaccine market share. Concerns over management's performance and potential outcomes for the company continue to fuel conversations.

Zoracles

Zoracles ($ZORA) is trending amidst community excitement over potential catalysts like government re-openings and tariff deals, which could spark an altcoin season. Community members are closely watching for news of listings and the impact of a digital asset infrastructure bill, particularly given ZORA's connection to Coinbase and the BASE ecosystem. Discussions also revolve around ZORA's potential to benefit from tokenization and its unique position within the crypto social media landscape.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amid anticipation of a potential spot ETF listing on Nasdaq this week, spurring excitement within the community, with some even speculating on significant price increases. Despite general market volatility impacting crypto, the XRP community is focused on the possibility of decoupling from broader market trends and the potential for new investment opportunities through ETFs. Discussions also include perspectives on the regulatory landscape and its impact on XRP's future.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is trending amidst community debate over its future and the impact of the newly launched Janction (JCT) token. Discussions range from accusations of a 'scam' to optimistic views about JCT's potential to boost the JASMY ecosystem and drive demand; technical analysis is also being shared to predict price movements.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney ($DIS) is trending amid discussions about its upcoming earnings report and potential performance catalysts. Community members are weighing bullish and bearish perspectives, considering factors like Disney's streaming strategy, theme park performance, and the recent YouTube TV dispute. Some traders are eyeing technical indicators and analyst price targets, while others focus on potential partnerships and upcoming content releases.

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Korro Bio Inc.

Korro Bio ($KRRO) is experiencing volatility as investors react to news of a paused research program and restructuring charges, despite the company having a strong cash position. Community discussions revolve around potential dead cat bounces and speculation about the stock being oversold. Some traders are focusing on quick scalps amid the uncertainty, while others see long-term potential based on the company's cash reserves and institutional ownership.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending amid discussions about its upcoming earnings report and the potential impact of the IPO lock-up period expiring. Community members are debating whether recent selling pressure is a buying opportunity or a sign of further decline, with some anticipating increased volatility. Speculation surrounds potential government contracts and the broader outlook for the stablecoin market.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending downward as concerns arise around the company's debt related to AI infrastructure investments, despite some analysts suggesting it's a buying opportunity. Community discussions revolve around management's silence amid the stock's decline and the potential impact of Michael Burry's negative outlook on AI hyperscalers. Some traders see a potential bottom forming, while others worry about a continued selloff.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Up 8.4% - Here's Why

MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Up 8.4% - Time to Buy...

CLASS ACTION REMINDER: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Lawsuit by December 15, 2025

CLASS ACTION REMINDER: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Lawsuit by December 15, 2025 CLASS ACTION REMINDER: Berger...

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman MLTX...

MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX

MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX MoonLake...

FY2025 EPS Estimates for MLTX Decreased by Leerink Partnrs

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Equities researchers at Leerink Partnrs cut their FY2025 earnings per share estimates for shares of MoonLake Immunotherapeutics in a research...

Equities Analysts Offer Predictions for MLTX FY2025 Earnings

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Stock analysts at Wedbush decreased their FY2025 EPS estimates for MoonLake Immunotherapeutics in a research report issued to clients and...

FY2029 Earnings Forecast for MLTX Issued By Wedbush

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Analysts at Wedbush decreased their FY2029 EPS estimates for MoonLake Immunotherapeutics in a research note issued to investors on Wednesday...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Average Recommendation of "Hold" from Analysts

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) has been given an average recommendation of "Hold" by the fifteen ratings firms that are currently covering the stock, Marketbeat Ratings...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...

MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$12.83
Prev Close	$11.75
Open	$11.83
Dividend Yield	0.00%
50-Day Moving Average	$26.13
Beta	0.51
Avg. Volume	6.18M
PE Ratio	-3.53

52-Week High	$62.75
52-Week Low	$5.95
Market Capitalization	$838.64M
EPS (Annual)	-$1.89
Price to Book	2.59
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

MLTX
MoonLake Immunotherapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MLTX News

MLTXMoonLake Immunotherapeutics